Antihypertensive Medication as a Risk Factor For Basal Cell Carcinoma: A Nationwide Registry-based Case-control Study
Open Access
- 23 September 2025
- journal article
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 105, adv42749
Abstract
Hydrochlorothiazide has been associated with increased cutaneous squamous cell carcinoma risk. Meanwhile, its association with basal cell carcinoma (BCC) risk is controversial. The association between commonly prescribed antihypertensive medications and BCC risk in the Swedish population was investigated. All cases with a histopathologically verified BCC in Sweden during 2007–2017 and 2 matched controls per case were included in this nationwide, registry-based, case-control study. Information on prescribed anti-hypertensive drugs, comorbidities, co-medications, and socioeconomic factors was retrieved from nationwide registries. The odds of being treated with any of the chosen treatments in relation to BCC diagnosis were estimated. In total, 133,539 cases and 257,849 controls were studied. Thiazide-containing combination treatments (OR 1.09), angiotensin II receptor blockers (OR 1.09), calcium channel blockers (OR 1.09), and beta-blockers (OR 1.07) were associated with an increased BCC risk. Use of single-agent thiazide treat-ment did not affect BCC risk. In conclusion, statistically significant associations were found between several commonly prescribed antihypertensives and an increased BCC risk. Thiazide treatment affected BCC risk only when given as combination treatment, indicating that relevant adjunctive substances should be studied further in relation to BCC risk. Presently, it is suggested that prevention efforts focus on UV protection rather than altering antihypertensive treatments.Keywords
This publication has 32 references indexed in Scilit:
- Use of hydrochlorothiazide and risk of skin cancer in a large nested case‐control study in SpainPharmacoepidemiology and Drug Safety, 2021
- Association between hydrochlorothiazide and the risk of in situ and invasive squamous cell skin carcinoma and basal cell carcinoma: A population-based case-control studyJournal of the American Academy of Dermatology, 2021
- Use of Hydrochlorothiazide and Risk of Melanoma and Nonmelanoma Skin CancerDrug Safety, 2020
- Association study indicates combined effect of interleukin-10 and angiotensin-converting enzyme in basal cell carcinoma developmentArchives of Dermatological Research, 2020
- Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from DenmarkJournal of the American Academy of Dermatology, 2018
- Use of antihypertensive drugs and risk of keratinocyte carcinoma: A meta‐analysis of observational studiesPharmacoepidemiology and Drug Safety, 2018
- Exposure to phototoxic NSAIDs and quinolones is associated with an increased risk of melanomaEuropean Journal of Clinical Pharmacology, 2013
- Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with decreased risk for basal cell carcinomaArchives of Dermatological Research, 2013
- High-ceiling diuretics are associated with an increased risk of basal cell carcinoma in a population-based follow-up studyEuropean Journal of Cancer, 2010
- Risk Factors for Single and Multiple Basal Cell CarcinomasArchives of Dermatology, 2010